- Home
- HTLD vs ORKA Comparison
HTLD vs ORKA Comparison
Compare HTLD & ORKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTLD
- ORKA
- Stock Information
- Founded
- HTLD 1978
- ORKA 2004
- Country
- HTLD United States
- ORKA United States
- Employees
- HTLD N/A
- ORKA N/A
- Industry
- HTLD Trucking Freight/Courier Services
- ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- HTLD Industrials
- ORKA Health Care
- Exchange
- HTLD Nasdaq
- ORKA Nasdaq
- Market Cap
- HTLD 886.5M
- ORKA 1.0B
- IPO Year
- HTLD N/A
- ORKA N/A
- Fundamental
- Price
- HTLD $10.64
- ORKA $11.02
- Analyst Decision
- HTLD Sell
- ORKA Strong Buy
- Analyst Count
- HTLD 4
- ORKA 7
- Target Price
- HTLD $11.75
- ORKA $39.67
- AVG Volume (30 Days)
- HTLD 496.4K
- ORKA 261.1K
- Earning Date
- HTLD 01-28-2025
- ORKA 03-04-2025
- Dividend Yield
- HTLD 0.77%
- ORKA N/A
- EPS Growth
- HTLD N/A
- ORKA N/A
- EPS
- HTLD N/A
- ORKA N/A
- Revenue
- HTLD $1,047,511,000.00
- ORKA N/A
- Revenue This Year
- HTLD $0.24
- ORKA N/A
- Revenue Next Year
- HTLD $7.05
- ORKA N/A
- P/E Ratio
- HTLD N/A
- ORKA N/A
- Revenue Growth
- HTLD N/A
- ORKA N/A
- 52 Week Low
- HTLD $9.63
- ORKA $10.61
- 52 Week High
- HTLD $13.67
- ORKA $53.88
- Technical
- Relative Strength Index (RSI)
- HTLD 36.93
- ORKA N/A
- Support Level
- HTLD $11.21
- ORKA N/A
- Resistance Level
- HTLD $11.67
- ORKA N/A
- Average True Range (ATR)
- HTLD 0.31
- ORKA 0.00
- MACD
- HTLD -0.09
- ORKA 0.00
- Stochastic Oscillator
- HTLD 22.88
- ORKA 0.00
About HTLD Heartland Express Inc.
Heartland Express Inc is engaged in providing truckload services across the United States and Canada. These truckload services are asset-based transportation services in the dry van truckload market, and it also offers truckload temperature-controlled transportation services. The company's majority customers represent the consumer goods, appliances, food products, and automotive industries.
About ORKA Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics Inc is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. It is to offer patients suffering from chronic skin diseases like plaque psoriasis.